Diabetes

With the new software, healthcare providers, patients and caregivers will now have glucose readings from a sensor that are closest yet to lab accuracy.

Norwest Venture Partners (NVP) led the round with participation from Mosaic Health Solutions, as well as existing investors Sequoia and Qualcomm.

The remote mobile communications device used for Continuous Glucose Monitoring (CGM) has cleared the regulatory hurdle and is now ready to be sold in the U.S.

The application is not compatible with standard measurements used in the UK and Australia where blood glucose levels are measured in mmol/L.

Glooko's diabetes management platform enables remote patient monitoring by syncing blood glucose readings from 30+ meters to supported iOS and Android devices.

The study involved some 200 people with diabetes all of whom followed their regular drug regimen; half of the participants used the Healthmeter device.

The company will use the funding to support the testing and uptake of Prevent, Omada's online diabetes prevention program, with low-income populations.

Backed by $10 million from the venture capital firm General Catalyst, Livongo is working on a new way to test and monitor insulin levels for diabetics.

Mission T1D aims to improve the understanding of type 1 diabetes amongst young sufferers by allowing them to play, learn and share knowledge.

Gmate SMART meter connects to the headphone jack of an iOS device and with an accompanying mobile app, it delivers accurate and fast blood glucose results.